These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 26276951)

  • 21. All-Optical Electrophysiology Refines Populations of In Silico Human iPSC-CMs for Drug Evaluation.
    Paci M; Passini E; Klimas A; Severi S; Hyttinen J; Rodriguez B; Entcheva E
    Biophys J; 2020 May; 118(10):2596-2611. PubMed ID: 32298635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report on: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes-An Artifact by Big Conductance Calcium Activated Potassium Current (I
    Horváth A; Christ T; Koivumäki JT; Prondzynski M; Zech ATL; Spohn M; Saleem U; Mannhardt I; Ulmer B; Girdauskas E; Meyer C; Hansen A; Eschenhagen T; Lemoine MD
    Cells; 2020 Jan; 9(1):. PubMed ID: 31968557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
    Wang L; Wada Y; Ballan N; Schmeckpeper J; Huang J; Rau CD; Wang Y; Gepstein L; Knollmann BC
    J Mol Cell Cardiol; 2021 Dec; 161():130-138. PubMed ID: 34400182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers.
    Altrocchi C; de Korte T; Bernardi J; Spätjens RLHMG; Braam SR; Heijman J; Zaza A; Volders PGA
    Europace; 2020 Sep; 22(9):1431-1441. PubMed ID: 32770183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.
    Winbo A; Ramanan S; Eugster E; Jovinge S; Skinner JR; Montgomery JM
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H927-H937. PubMed ID: 32822546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
    Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
    J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mathematical model of hiPSC cardiomyocytes electromechanics.
    Forouzandehmehr M; Koivumäki JT; Hyttinen J; Paci M
    Physiol Rep; 2021 Nov; 9(22):e15124. PubMed ID: 34825519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
    Passini E; Mincholé A; Coppini R; Cerbai E; Rodriguez B; Severi S; Bueno-Orovio A
    J Mol Cell Cardiol; 2016 Jul; 96():72-81. PubMed ID: 26385634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
    Guo L; Qian JY; Abrams R; Tang HM; Weiser T; Sanders MJ; Kolaja KL
    Cell Physiol Biochem; 2011; 27(5):453-62. PubMed ID: 21691062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impacts of DCM-linked gating pore currents on the electrophysiological characteristics of hiPSC-CM monolayers.
    Djemai M; Jalouli M; Chahine M
    Biochem Biophys Res Commun; 2024 Sep; 723():150175. PubMed ID: 38820625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
    Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
    SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
    Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
    J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Immaturity of Human iPSC-Derived Cardiomyocytes:
    Koivumäki JT; Naumenko N; Tuomainen T; Takalo J; Oksanen M; Puttonen KA; Lehtonen Š; Kuusisto J; Laakso M; Koistinaho J; Tavi P
    Front Physiol; 2018; 9():80. PubMed ID: 29467678
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability.
    Sheng X; Reppel M; Nguemo F; Mohammad FI; Kuzmenkin A; Hescheler J; Pfannkuche K
    PLoS One; 2012; 7(9):e45963. PubMed ID: 23029342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.